(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-12 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 505790
| Date | Daily Closing Price | Open | High | Low | Volume |
| 12 Wed Jun 2024 | 106.14 | 107.54 | 108.78 | 104.46 | 1.318 times |
| 11 Tue Jun 2024 | 105.40 | 103.13 | 105.96 | 101.73 | 1.067 times |
| 10 Mon Jun 2024 | 104.03 | 102.40 | 104.41 | 100.67 | 1.437 times |
| 07 Fri Jun 2024 | 103.34 | 103.80 | 106.28 | 101.24 | 0.542 times |
| 06 Thu Jun 2024 | 104.42 | 105.16 | 105.64 | 103.64 | 0.747 times |
| 05 Wed Jun 2024 | 105.82 | 102.04 | 106.52 | 100.81 | 0.916 times |
| 04 Tue Jun 2024 | 101.89 | 104.91 | 105.38 | 101.62 | 0.853 times |
| 03 Mon Jun 2024 | 104.84 | 106.43 | 109.37 | 101.87 | 1.177 times |
| 31 Fri May 2024 | 105.56 | 107.83 | 108.53 | 104.30 | 1.248 times |
| 30 Thu May 2024 | 106.36 | 101.82 | 106.72 | 101.09 | 1.266 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 106.1, but if it comes below 106.1, then a intra day sell could be more profitable.
If you take a sell trade below 106.1, then use 106.1 as stoploss and 104.38 as target. However if you take a buy trade in stock , then use 106.1 as stoploss and 108.1 as target.
Share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Target | 72.24 |
| Downside Target | 84.33 |
| Downside Target | 90.85 |
| Downside Target | 97.00 |
| Downside Target | 103.23 |
| Downside Target | 105.64 |
| Upside Target | 108.53 |
| Upside Target | 108.78 |
| Upside Target | 109.37 |
| Upside Target | 111.02 |
Intraday share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Intraday Target | 101.61 |
| Downside Intraday Target | 97.09 |
| Upside Intraday Target | 109.72 |
| Upside Intraday Target | 113.31 |
| Downside Intraday Target | 105.2 |
Weekly technical analysis of Blueprint Medicines (BPMC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 12 Wed Jun 2024 | 106.14 | 102.40 | 108.78 | 100.67 | 0.903 times |
| 07 Fri Jun 2024 | 103.34 | 106.43 | 109.37 | 100.81 | 0.89 times |
| 31 Fri May 2024 | 105.56 | 103.88 | 108.53 | 99.16 | 1.32 times |
| 23 Thu May 2024 | 102.39 | 104.87 | 105.64 | 101.21 | 0.717 times |
| 17 Fri May 2024 | 104.96 | 109.16 | 111.02 | 103.23 | 0.848 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 12 Wed Jun 2024 | 106.14 | 106.43 | 109.37 | 100.67 | 0.298 times |
| 31 Fri May 2024 | 105.56 | 91.44 | 111.02 | 90.85 | 1.009 times |
| 30 Tue Apr 2024 | 91.34 | 95.00 | 97.00 | 84.33 | 0.835 times |
| 28 Thu Mar 2024 | 94.86 | 93.81 | 98.06 | 84.81 | 0.82 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 104.96 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 104.96 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.